Immunostaining with diagnostic markers such as cytokeratin 20 (CK20) and thyroid transcription factor 1 (TTF-1) can help differentiate these two cancers, but their sensitivity and specificity are limited. This evidence concerns the gene NKX2-1 and cancer.